E
Ultragenyx Pharmaceutical Inc. RARE
$39.34 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -569.18M -558.99M -585.12M -613.35M -606.64M
Total Depreciation and Amortization 35.54M 34.68M 33.12M 29.62M 26.01M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 105.53M 101.25M 106.09M 107.83M 120.93M
Change in Net Operating Assets 13.92M 4.47M -23.56M -32.76M -15.10M
Cash from Operations -414.19M -418.59M -469.47M -508.67M -474.81M
Capital Expenditure -7.49M -8.44M -10.52M -22.44M -44.27M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -10.28M -219.08M 122.79M 173.58M 212.27M
Cash from Investing -17.77M -227.52M 112.28M 151.13M 168.00M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 392.24M 719.67M 740.73M 388.17M 388.17M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 7.00M 7.00M 0.00 636.00K -28.00K
Cash from Financing 399.24M 726.67M 740.73M 388.81M 388.14M
Foreign Exchange rate Adjustments -2.53M 1.05M -940.00K -428.00K 462.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -35.24M 81.61M 382.59M 30.84M 81.80M
Weiss Ratings